Dashboard
Manage Tickers

ANNXAnnexon, Inc.

Nasdaq annexonbio.com


$ 4.37 $ -0.13 (-2.89 %)    

Thursday, 16-May-2024 15:59:23 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 451.64 $ -1.83 (-0.4 %)
DIA $ 399.14 $ -0.07 (-0.02 %)
SPY $ 528.49 $ -1.29 (-0.24 %)
TLT $ 92.06 $ -0.04 (-0.04 %)
GLD $ 220.06 $ -0.86 (-0.39 %)
$ 4.36
$ 4.46
$ 4.34 x 119
$ 0.00 x 0
$ 4.29 - $ 4.55
$ 1.57 - $ 8.40
2,955,662
na
552.03M
$ 1.20
$ 40.89
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-13-2024 03-31-2024 10-Q
2 03-26-2024 12-31-2023 10-K
3 11-13-2023 09-30-2023 10-Q
4 08-07-2023 06-30-2023 10-Q
5 05-08-2023 03-31-2023 10-Q
6 03-06-2023 12-31-2022 10-K
7 11-03-2022 09-30-2022 10-Q
8 08-08-2022 06-30-2022 10-Q
9 05-09-2022 03-31-2022 10-Q
10 03-01-2022 12-31-2021 10-K
11 11-09-2021 09-30-2021 10-Q
12 08-16-2021 06-30-2021 10-Q
13 05-17-2021 03-31-2021 10-Q
14 03-25-2021 12-31-2020 10-K
15 11-16-2020 09-30-2020 10-Q
16 09-08-2020 06-30-2020 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

wells-fargo-maintains-overweight-on-annexon-lowers-price-target-to-10
Wells Fargo Maintains Overweight on Annexo...
05/15/2024 18:12:27

Wells Fargo analyst Derek Archila maintains Annexon (NASDAQ:ANNX) with a Overweight and lowers the price target from $12 to ...

hc-wainwright--co-reiterates-buy-on-annexon-maintains-30-price-target
HC Wainwright & Co. Reiterates Buy on Anne...
05/14/2024 11:03:44

HC Wainwright & Co. analyst Andrew Fein reiterates Annexon (NASDAQ:ANNX) with a Buy and maintains $30 price target.

needham-reiterates-buy-on-annexon-maintains-16-price-target
Needham Reiterates Buy on Annexon, Maintai...
05/13/2024 15:14:50

Needham analyst Joseph Stringer reiterates Annexon (NASDAQ:ANNX) with a Buy and maintains $16 price target.

annexon-q1-eps-021-beats-035-estimate
Annexon Q1 EPS $(0.21) Beats $(0.35) Estimate
05/13/2024 12:14:35

Annexon (NASDAQ:ANNX) reported quarterly losses of $(0.21) per share which beat the analyst consensus estimate of $(0.35) by 40...

annexon-to-present-data-of-additional-phas3-2-clinical-results-of-anx007-from-archer-trial-in-geographic-atrophy-including-further-analyses-of-visual-acuity-and-photoreceptor-preservation-at-arvo-2024-annual-meeting
Annexon To Present Data Of Additional Phas...
05/01/2024 12:27:42

Additional data from the Phase 2 ARCHER trial demonstrating protection of visual acuity and anatomical structure following ANX0...

cantor-fitzgerald-reiterates-overweight-on-annexon
Cantor Fitzgerald Reiterates Overweight on...
04/24/2024 12:54:56

Cantor Fitzgerald analyst Pete Stavropoulos reiterates Annexon (NASDAQ:ANNX) with a Overweight.

needham-reiterates-buy-on-annexon-maintains-16-price-target
Needham Reiterates Buy on Annexon, Maintai...
04/11/2024 11:17:33

Needham analyst Joseph Stringer reiterates Annexon (NASDAQ:ANNX) with a Buy and maintains $16 price target.

10-health-care-stocks-with-whale-alerts-in-todays-session
10 Health Care Stocks With Whale Alerts In...
04/09/2024 17:35:25

annexon-inc-entered-sales-agreement-relating-to-sale-of-shares-of-common-stock-may-offer-shares-of-common-stock-from-time-to-time-for-100m
Annexon Inc Entered Sales Agreement Relati...
04/05/2024 20:13:40

- SEC Filing

cantor-fitzgerald-reiterates-overweight-on-annexon
Cantor Fitzgerald Reiterates Overweight on...
04/03/2024 13:33:13

Cantor Fitzgerald analyst Pete Stavropoulos reiterates Annexon (NASDAQ:ANNX) with a Overweight.

wells-fargo-maintains-overweight-on-annexon-maintains-12-price-target
Wells Fargo Maintains Overweight on Annexo...
04/01/2024 15:56:38

Wells Fargo analyst Derek Archila maintains Annexon (NASDAQ:ANNX) with a Overweight and maintains $12 price target.

jp-morgan-maintains-overweight-on-annexon-raises-price-target-to-13
JP Morgan Maintains Overweight on Annexon,...
04/01/2024 13:53:42

JP Morgan analyst Anupam Rama maintains Annexon (NASDAQ:ANNX) with a Overweight and raises the price target from $11 to $13.

b-of-a-securities-maintains-buy-on-annexon-raises-price-target-to-10
B of A Securities Maintains Buy on Annexon...
03/28/2024 18:14:53

B of A Securities analyst Tazeen Ahmad maintains Annexon (NASDAQ:ANNX) with a Buy and raises the price target from $7 to $10.

cintas-reports-upbeat-earnings-joins-paysign-noah-holdings-and-other-big-stocks-moving-higher-on-wednesday
Cintas Reports Upbeat Earnings, Joins PayS...
03/27/2024 14:03:27

U.S. stocks were higher, with the Dow Jones index gaining around 300 points on Wednesday.

hc-wainwright--co-maintains-buy-on-annexon-maintains-30-price-target
HC Wainwright & Co. Maintains Buy on Annex...
03/27/2024 13:03:59

HC Wainwright & Co. analyst Andrew Fein maintains Annexon (NASDAQ:ANNX) with a Buy and maintains $30 price target.

wells-fargo-maintains-overweight-on-annexon-raises-price-target-to-12
Wells Fargo Maintains Overweight on Annexo...
03/27/2024 12:56:18

Wells Fargo analyst Derek Archila maintains Annexon (NASDAQ:ANNX) with a Overweight and raises the price target from $11 to ...

needham-reiterates-buy-on-annexon-maintains-16-price-target
Needham Reiterates Buy on Annexon, Maintai...
03/27/2024 10:53:30

Needham analyst Joseph Stringer reiterates Annexon (NASDAQ:ANNX) with a Buy and maintains $16 price target.

annexon-filed-for-mixed-shelf-offering-of-up-to-400m
Annexon Filed For Mixed Shelf Offering Of ...
03/26/2024 21:08:59

annexon-q4-eps-036-beats-048-estimate
Annexon Q4 EPS $(0.36) Beats $(0.48) Estimate
03/26/2024 20:30:57

Annexon (NASDAQ:ANNX) reported quarterly losses of $(0.36) per share which beat the analyst consensus estimate of $(0.48) by 25...

why-cutera-shares-are-trading-lower-by-over-26-here-are-other-stocks-moving-in-fridays-mid-day-session
Why Cutera Shares Are Trading Lower By Ove...
03/22/2024 18:39:16

Shares of Cutera, Inc. (NASDAQ: CUTR) fell sharply during Friday’s session after the company reported worse-than-expected four...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION